Qbic Fund
Edit

Qbic Fund

https://www.qbic.be
Last activity: 13.05.2024
Qbic is a seed and early-stage and sector agnostic inter-university fund investing in spin-offs and young innovating companies that have a technology link with Qbic’s partner universities and research institutions. Qbic is managed by an independent team of seasoned investment and business professionals. The first Qbic fund - Qbic I - was incorporated in 2012 with a capital of € 40,7 million and invested in 18 companies. Qbic I is currently focusing on follow on investments and exits. The second Qbic fund - Qbic II - started in December 2016 and has a capital € of 58,9 million. With in aggregate close to € 100 million under management, Qbic is one of the largest inter-university spin-off funds in Europe.
News
35
Portfolio
4
Persons
19
Mentions
14
Location: Belgium, East Flanders, Ghent
Employees: 11-50
Founded date: 2012
Investment Type: Venture Capital
Investment Stage: Pre-Seed; Seed; Series A

Portfolio 4

DateNameWebsiteTotal RaisedLocation
26.09.2023Abscint: M...abscint.com$3.18MBelgium, B...
21.12.2021Accelleranaccelleran.com$19.39MBelgium, A...
06.12.2021Trince Biotrincebio.com$4.53MBelgium, E...
06.10.2014Biogazelleservices.biogazelle.com$2.5MBelgium, E...

Persons 19

DateFirst NameLast NameTitleLinkedInLocation
-CédricVan NevelPartner Qb...linkedin.c...-
-SaraVandenwijn...Junior Par...linkedin.c...-
-MarcZabeauManaging P...linkedin.c...-
-SofieBaetenManaging P...linkedin.c...-
-DannyGonnissenPartner Qb...linkedin.c...-
-WimVan CampVenture Pa...linkedin.c...-
-StevenLeuridanPartner Qb...linkedin.c...-
-JohanBrantsAdvisory B...-
-VincentLendersInvestment...linkedin.c...-
-GuyHuylebroec...Partner Qb...linkedin.c...-
Show more

News 35

DateTitleDescription
24.04.2024Flindr raises €20 million in Series AOSS, Netherlands, 24 April 2024 – Flindr Therapeutics B.V. (“Flindr” or “the Company”), a precision oncology therapeutics company, today announces a €20 million Series A financing to advance its pipeline of first-in-class, small molecule in...
18.04.2024AmphiStar raises €6 million in Seed fundingGhent, Belgium, April 18, 2024 - European Circular Bioeconomy Fund (ECBF), Qbic III and Flanders Future Tech Fund (FFTF) have joined forces to provide a significant boost to Ghent-based start-up AmphiStar. The funding round, led by ECBF, ra...
07.02.2024VoxelSensors raises an additional €3 Million in Seed ExtensionBrussels, Belgium, 30 January 2024 - VoxelSensors, a leading Belgian semiconductor deep tech start-up, closes its Seed Round with a €3 million in tail investment led by a new investor SFPIM Relaunch with participation from existing investor...
07.02.2024Blue Foot Membranes raises €10 million roundLommel, Belgium, 06 February 2024 - Blue Foot Membranes NV (“Blue Foot”), the provider of unique backwashable flat sheet membranes for MBR applications, announces the closing of a €10 million growth stage round, led by Circular Innovation F...
06.12.2023Tanai Therapeutics raises € 2.85 million round in Seed fundingGhent, 6 December 2023 – VIB, Flanders’ leading life sciences institute, together with lead investor V-Bio Ventures has launched a new spin-off company based on research at the VIB-UGent Center for Inflammation Research. With an initial see...
06.12.2023Obulytix raises € 4 million round in Seed fundingObulytix, a spin-off based on research results from Ghent University and KU Leuven, has built a platform that creates new ways to tackle bacterial infections. The innovative, phage lysin-based platform – leveraging the power of artificial i...
26.09.2023ABSCINT raises € 3 million round to initiate Phase II Clinical TrialsBrussels, Liège, September 25, 2023 - ABSCINT has secured EUR 3 million for its technology platform that enables rapid targeting and visualisation of specific molecular markers throughout the entire body via a PET scan. ABSCINT is actively ...
07.09.2023Axithra raises € 10 million in Seed fundingLeuven and Ghent (Belgium), 5 September, 2023 – Axithra, a new spin-off of imec and Ghent University, today announced a 10 million euro seed round, securing the first two years of R&D. Axithra develops a technology platform for therapeu...
11.07.2023Aphea.bio raises a € 70 million Series C roundGent, Belgium, 11 July 2023 – Aphea.Bio, a Belgium-based agricultural technology company, announced today the successful closing of its Series C Funding round, securing € 70 million. The round was led by Innovation Industries, joined by Kor...
07.07.2023Final closing brings Qbic III to 88.5 million eurosSt-Denijs-Westrem, Belgium, July, 5th 2023 – Qbic, the Belgian interuniversity venture capital fund that catalyzes the translation of promising technological developments from research institutions to sustainable companies, closes a second ...
Show more

Mentions in press and media 14

DateTitleDescription
25.04.2024Dutch-based Flindr Therapeutics secures €20M to discover and develop precision oncology therapeuticsRead this article in: Netherlands-based Flindr Therapeutics, a company focused on precision cancer treatments, announced that it has secured €20M in a Series A round of funding. This funding will help advance the Dutch company’s cancer trea...
18.04.2024AmphiStar raises €6M to recycle wasteGhent-based Bioengineering startup Amphistar has raised €6M from European Circular Bioeconomy Fund (ECBF), Qbic III and Flanders Future Tech Fund (FFTF) to derive surfactants from waste. Surfactants play a pivotal role in everyday products ...
26.09.2023ABSCINT raises € 3 million round to initiate Phase II Clinical TrialsBrussels, Liège, September 25, 2023 - ABSCINT has secured EUR 3 million for its technology platform that enables rapid targeting and visualisation of specific molecular markers throughout the entire body via a PET scan. ABSCINT is actively ...
18.05.2023Belgium-based VoxelSensors secures €5M for its ‘revolutionary’ 3D perception solutionsBrussels-based VoxelSensors, a company that blends the physical and digital worlds through revolutionary 3D perception solutions, announced on Thursday that it has secured €5M in a seed round of funding. The round was led by Belgium-based v...
17.06.2022Belgium-based Aloxy raises €3.8M for its plug-and-play Industrial IoT platformAntwerp, Belgium-based Aloxy, a company that enables industrial Internet of Things (IoT) by offering a modular IoT platform for the petrochemical industry, announced that it has raised €3.8M in a fresh round of funding. In the coming year, ...
25.03.2022Belgian health tech firm gets dose of €3.4 million to become one-stop shop for European hospital dataBelgian health tech startup Cascador Health has raised €3.4 million to further boost its data platform and European expansion. The round saw the participation of Qbic, Volta Ventures and Theodorus and Swiss healthcare provider Hirslanden. T...
23.03.2022Qbic Holds First Close of New Fund, at EUR 49MQbic, a St-Denijs-Westrem, Belgium inter-university venture capital firm focusing on the transformation of technological breakthroughs into sustainable businesses, held the first close of its third fund at EUR 49m. Qbic III sees continued c...
23.12.2021Trince raises € 4M with support of Qbic IIGhent, Belgium, 4 December 2021 – Trince, a spin-off of Ghent University (UGent), is developing innovative and efficient technology to insert genetic material into cells. This genetic modification of cells is essential in, for example, cell...
21.12.2021Accelleran raises € 6.8M with support of Qbic IIAs 5G network deployments accelerate across the globe and the OpenRAN system of standards gathers momentum, service providers from mobile operators to edge computing infrastructure providers to system integrators are turning to Accelleran’s...
07.10.2021Sentea raises 2.3 million Euros to support the growth of its fiber optic sensing businessGhent (Belgium) – October 7th, 2021 – Sentea, a leading supplier of read-out systems for fiber optic sensor, today announced to have successfully raised 2.3 million Euros to further expand its business. The investment round is supported by ...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In